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The subjective nature of self-reported dietary intake assessment methods presents numerous challenges to
obtaining accurate dietary intake and nutritional status. This limitation can be overcome by the use of dietary
biomarkers, which are able to objectively assess dietary consumption (or exposure) without the bias of self-reported
dietary intake errors. The need for dietary biomarkers was addressed by the Institute of Medicine, who recognized
the lack of nutritional biomarkers as a knowledge gap requiring future research. The purpose of this article is to
review existing literature on currently available dietary biomarkers, including novel biomarkers of specific foods and
dietary components, and assess the validity, reliability and sensitivity of the markers. This review revealed several
biomarkers in need of additional validation research; research is also needed to produce sensitive, specific,
cost-effective and noninvasive dietary biomarkers. The emerging field of metabolomics may help to advance the
development of food/nutrient biomarkers, yet advances in food metabolome databases are needed. The availability
of biomarkers that estimate intake of specific foods and dietary components could greatly enhance nutritional
research targeting compliance to national recommendations as well as direct associations with disease outcomes.
More research is necessary to refine existing biomarkers by accounting for confounding factors, to establish new
indicators of specific food intake, and to develop techniques that are cost-effective, noninvasive, rapid and accurate
measures of nutritional status.
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Collecting dietary intake data is associated with many
challenges, which are primarily related to the subjective
nature of data collection tools such as food frequency
questionnaires (FFQ), multiple-day food records and
24-hour dietary recalls. Individuals are not always able
to recall all foods consumed or the specific components
of the food (e.g., condiments in sandwiches), have diffi-
culty determining accurate portion sizes and typically
underreport dietary intake [1-4]. Each method has
strengths and limitations; however, food records and
dietary recalls typically are costly (resource-intensive),
time consuming, place a high burden on respondents,
provide only recent intake information (i.e., not habitual
intake patterns) and are not always feasible in large-
scale investigations or in those including low income or* Correspondence: vhedrick@vt.edu
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reproduction in any medium, provided the orlow literacy populations [4-6]. A FFQ may provide a
glimpse into a population’s habitual dietary intake over
time, whereas food records and dietary recalls assess
days/weeks, which may be more precise but not repre-
sentative of typical intake over time [4]. Additionally,
several technological advances in dietary assessment
methods have occurred over the past few years, specif-
ically with computer software and web-based applica-
tions [7]. The Nutrition Data System for Research,
developed by the University of Minnesota, is a com-
monly utilized software program that allows for
interview-administered 24 hour dietary recalls as well
as researcher-entered multiple day food records [8].
The automated multiple-pass method is a 24-hour diet-
ary intake assessment method that is automated but
still interview administered [7]. Most recently, the auto-
mated self-administered 24-hour dietary recall (ASA24)
has been developed and based off of the automated
multiple-pass method. In addition to the ASA24 being
self-administered, further benefits include the format ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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at any location; thus decreasing researcher and partici-
pant burden [9]. Although these advances are promis-
ing, as well as cost-effective, using self-reported dietary
intake methods to assess dietary intake is still not with-
out intake error, a commonly cited research limitation
[3]. In contrast, biomarkers of food or nutrient intake
(or exposure) are able to objectively assess dietary in-
take/status without the bias of self-reported dietary in-
take errors [10-12], and also overcome the problem of
intra-individual diet variability [2]. The Institute of
Medicine has recognized the lack of nutritional biomar-
kers as a knowledge gap requiring future research, in-
cluding: 1) the need for biomarkers that can predict
functional outcomes and chronic diseases, and 2) the
need to improve dietary assessment and planning meth-
ods [10]. Dietary biomarkers are not without limita-
tions; cost and degree of invasiveness are factors to
consider [3]. Therefore, the need for non-invasive, inex-
pensive and specific dietary markers is clear [10].
Dietary biomarkers are desirable for their ability to
more accurately assess nutritional intake/status versus
self-reported methods, validate self-reported intake mea-
sures, evaluate intake of dietary items when food-
composition databases are inadequate, and to more
accurately associate dietary intake with disease risk and
nutritional status [13]. Biomarkers can be categorized
into short-term (reflecting intake over past hours/days),
medium-term (reflecting intake over weeks/months) and
long-term markers (reflecting intake over months/years),
with the type of sample used being a main determinant
of time (e.g., blood, hair, adipose tissue) [13].
Although dietary biomarkers generally provide a more
proximal measure of dietary intake, factors which may not
present in traditional dietary assessment methods could
skew biomarker measures of dietary intake. Such factors
could include genetic variability, lifestyle/physiologic factors
(e.g., smoking), dietary factors (e.g., nutrient-nutrient inter-
action), biological sample and analytical methodology [14].
Unfortunately, little research is available which addresses
this issue. As a result, it is imperative to assess a biomar-
ker’s validity, reproducibility, ability to detect changes over
time and robustness across diverse populations, as well as
strengths and limitations to ensure it is evaluated using the
proper techniques.
As the profession of dietetics and health sciences
trends towards individualized nutrition [12,15], develop-
ing biomarkers that measure intake of specific foods, ra-
ther than nutrients, may become a primary focus [2].
The emerging field of metabolomics in human nutrition
may advance the discovery of novel biomarkers for spe-
cific dietary intake and consequently health status [16].
Metabolomics is the identification of small molecule
metabolites and nutrients available in biological fluids(blood, saliva, urine, etc.) that makes up the metabolome
[17,18]. The metabolites are the products of metabolism
of medicines, foods, toxins, etc. [18,19]. Metabolomics
has been used to identify dietary intake patterns by iden-
tifying the molecules that vary between different diets
[17], which can be useful in determining potential mar-
kers of diet-disease risk [20], as well as the potential to
discover novel biomarkers for specific foods [21]. The
availability of biomarkers that provide estimates of spe-
cific foods and dietary components intake could greatly
enhance nutritional research targeting compliance to na-
tional recommendations, such as the U.S. 2010 Dietary
Guidelines and those of the American Heart Association.
The purpose of this review is to present and evaluate
available literature regarding the validity, reliability and
sensitivity of current dietary biomarkers for macronutri-
ent dietary component/foods (carbohydrates, fats, pro-
teins), as well as food/nutrients which cannot be
categorized within macronutrients (e.g., caffeine). To our
knowledge, no review has addressed biomarkers for in-
take of specific foods and dietary components. Therefore
the present review will include an evaluation of research
investigating novel biomarkers for specific foods/dietary
components (e.g., 13C for corn and cane sugars [22]).
This review aims to provide a critical examination of the
available methods for measuring traditional macronutri-
ent intake/status that have been updated or modified in
the past decade and assess validity, reproducibility and
sensitivity of proposed and accepted biomarkers.
Methods
A literature search (Figure 1) was conducted in September
2012. Stage 1 consisted of an electronic search of the key-
words “dietary biomarkers” using PubMed (MEDLINE
database). The review was limited to clinical trials, meta-
analysis, randomized controlled trials, validation studies,
journal articles and reviews published within the past dec-
ade (Feb. 2001-Sept. 2012). This search identified 1,321
articles, which was further refined by limiting the search to
title/abstract text (n=251). Stage 2 involved a review of art-
icle title and abstract, which identified 118 articles. At
Stage 3, full texts of papers were downloaded and
assessed further for exclusion/inclusion criteria. To be
included in the review, the focus of the article had to be
intake biomarkers of macronutrients or specific foods/
dietary component intake. Exclusion criteria included the
following: biomarkers of disease-risk/health status (e.g.
cancer markers); biomarkers associated with weight sta-
tus, dietary supplements or medicines; biomarkers of oxi-
dative stress; micronutrient or antioxidant biomarkers;
pollutant or toxin biomarkers; and biomarkers of dietary
item function rather than biomarker of intake (e.g., effect
of fiber on colon health). Figure 1 presents an overview
of the review process.
First phase:  search of articles published between Feb. 2001-Sept. 2012 
with keywords "dietary biomarkers" (n=1,321)
Second phase of relevance selection: limit 
keywords to title/abstract (n=251) 
Third phase of relevance selection:  
title/abstract review
Articles retained for full text review (n=25)
Fourth phase of relevance selection:               
full text review (n=47)




Dietary function markers (3)
Questionnaire Development (3)
Not relevant to biomarkers (2)
Additional articles identified through 
reference search (22) 
Title/abstracts 
excluded (n=226)
Micronutrient/Antioxidant markers (42) 
Disease/Health markers (87)
Weight status markers (14)
Supplement/Medication studies (9)
Oxidative stress markers (20)
Dietary function markers (20)
Pollutant/Toxin markers (9)
Not relevant to biomarkers (25)
Full text 
excluded (n=14)
Figure 1 Flow diagram of the structured review of dietary biomarkers.
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Thirty-three articles were identified for inclusion. Bio-
markers were categorized under their respective macro-
nutrient, as well as an additional category for specific
dietary components that did not fall within the macro-
nutrient category (e.g., caffeine). Research findings are
summarized in the text in the following order: macronu-
trients (carbohydrates, fats and proteins) and specific
foods/dietary components. Recent literature related to
biomarkers for dietary macronutrients (carbohydrate, fat
and protein containing foods) is summarized in Table 1.
Carbohydrates
The American Heart Association and the U.S. 2010
Dietary Guidelines provide recommendations for added
sugar intake, as it is theorized that added sugars in the
diet, particularly sugar-sweetened beverages (SSB), have
contributed to the rise in obesity prevalence due to re-
search suggesting that they contribute to excessive en-
ergy intake [23-25]. Yet, significant evidence is neededto directly link SSB and added sugar intake to obesity
and other co-morbidities such as hypertension, diabetes
and cardiovascular disease [26-28]. Valid and reliable
biomarkers of sugar intake are needed to support exist-
ing dietary recommendations. Additionally, the U.S.
2010 Dietary Guidelines suggest one half of grains con-
sumed should be whole grains [29], due to associations
with heart health [30,31]. However, the general popula-
tion may have difficulty distinguishing whole grains from
refined grain products. Thus, a valid biomarker of whole
grain intake would provide greater insight into the influ-
ence of diet on health and disease outcomes [31].
Cane sugar and high fructose corn syrup
Carbon stable isotope abundance of 13C is a novel bio-
marker for cane sugar and high fructose corn syrup
(HFCS). Cane sugar and HFCS are derived from C4
plants (includes molasses, brown and powdered cane
sugar), making their intake measureable through 13C iso-
tope measures [32]. Cook et al. [33] used 13C from blood

















Cane Sugar/HFCS Cook et al.
(2009)
13C in blood glucose
(5 young adults)













Fingerstick NA-SIMS Medium term? r=0.365 (<0.05) r=0.873 (<0.001)
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GC-MS Short term R2=0.939 (<0.05)








DHBA Urine (24 hr) HPLC r= 0.359 (0.008)





Urine (24 hr) HPLC Short term
Total AR concentration











GC-MS Medium term r=0.53 (<0.001) r=0.38 (P<0.001)
Fats
Total Fat King et al.
(2006)






Fatty Acids Baylin et al.
(2002)
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Table 1 Summary of recent biomarker studies related to macronutrient foods (Continued)
Poppitt et al.
(2005)






RBC (fasting) GC Medium term r=0.45; 0.47*
(<0.001)
Total PUFA RBC (fasting) GC Medium term r=0.17h; 0.39*
(<0.001)
Total MUFA RBC (fasting) GC Medium term r=0.40; 0.48*
(<0.001)















Adipose tissue GLC Long term r=0.51; 0.52**
(<0.05)










RBC (fasting) GC Medium term r=0.23; 0.39*
(<0.05; <0.001)
Alpha-linolenic acid RBC (fasting) GC r=0.14hi, 0.07*hi
EPA, DHA Kuriki et al.
(2003)
EPA














Plasma (fasting) GC Long term r=0.91(<0.001) +











Hair CF-IRMS Medium term r=0.83 (0.001)
15N-DHA Hair CF-IRMS Medium term r=0.84 (<0.001)




Urine (24 hr) GC-MS Short term






















Urine (24 hr) Kjeldahl Short term R2=0.99i
Animal Protein Petzke & Lemke
(2009)
13C
(14 young adult females)












Urine (24 hr) Kinetic assay Short term Ptrend(<0.0001) +?
Taurine Urine (24 hr) IEC Short term? Ptrend(<0.0001) +?
1-methylhistidine Urine (24 hr) IEC Short term? Ptrend(<0.0001) +
3-methylhistidine Urine (24 hr) IEC Short term Ptrend(<0.0001) +
aHFCS, High fructose corn syrup; EPA, Eicosapentaenoic Acid; DHA, Docosahexaenoic Acid.
bDHBA, 3,5-Dihydroxybenzoic Acid; DHPPA, 3-(3,5-Dihydroxyphenyl)-Propanoic Acid; PUFA, Poly-Unsaturated Fatty Acid; MUFA, Mono-Unsaturated Fatty Acid; SFA, Saturated Fatty Acid; RBC, Red Blood Cell.
cGC-IRMS, gas chromatography isotope ratio mass; CF-SIRMS, Continuous-flow stable isotope ratio mass spectrometry; NA-SIMS, Natural abundance stable isotope mass spectrometry; GC-MS, Gas chromatography-mass spectrometry;
LC-MS, Liquid chromatography-mass spectrometry; TR-FIA, Time-resolved fluroimmunoassay; HPLC, High-performance liquid chromatography; 1D-TLC, One-dimensional thin-layer chromatography; GLC, Gas liquid chromatography;
GC, Gas chromatography; CF-IRMS, Continuous-flow isotope ratio mass spectrometry; GC/C/IRMS, Gas chromatography/combustion/ isotope ratio mass spectrometry; IEC, Ion-exchange chromatography.
dShort term: hours/days; Medium term: weeks/months; Long term: months/years.
eResults of comparsion of biomarkers to an appropriate dietary assessment method.
fRepresentative values from the literature.
gBiomarker is able to detect changes over time or distinguish high from low consumers; + = sensitivity has been demonstrated.
hCorrelation not significant.
iSignificance not reported.
*Values presented are pre, post menopausal, respectively.
**Values presented are alpha-linolenic, linoleic acid, respectively.
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sugar/HFCS; unfortunately, fasting glucose 13C levels
were inadequate indicators of intake as gluconeogenesis
caused 13C dilution. However, random plasma 13C mea-
surements showed high correlations with consumption
of cane sugar/HFCS from the previous meal (R2=0.90)
[33] and serum 13C levels were shown to be correlated
with SSB intake (r=0.18) in older adults [34]. Davy et al.
[22] used fingerstick blood samples to measure the 13C
isotope content, and reported higher correlations be-
tween SSB intake and 13C levels when compared to 13C
venipuncture samples [34]. Correlations with added
sugars (calories [kcals] and grams [g], r=0.37) and total
SSB (kcal and g, r=0.35, 0.28) were noted [22]. Addition-
ally, the reproducibility of 13C at 2 time points was found
to be significant (r=0.87) [22].
Although moderate correlations were found for
serum 13C to added sugars and SSB, there are limita-
tions that require further research before the 13C iso-
tope is considered a valid biomarker of cane sugar and
HFCS. While high correlations were found for random
plasma glucose 13C measures to cane sugar and HFCS,
this only reflects extremely recent intake (i.e., the pre-
vious meal). For this reason as well as less invasive-
ness, fingerstick serum 13C measures may be a better
choice (possibly reflects a longer intake period and is
less invasive) for a cane sugar/HFCS intake biomarker;
however, further research is warranted to determine
the intake period reflected in the measurement.
Beet sugar and maple syrup, which only account for a
small fraction of added sugars in the diet, are not cap-
tured by 13C measures as they are C3 plants, as well,
honey is not included [32]. Thus, biomarkers for sugar
intake that rely on 13C isotopes are only able to capture
part of the general US population’s intake; even so, this
does reflect a large portion of the consumed added
sugars. Another limitation of using 13C isotopes is that
corn is also a C4 plant; thus corn, corn derivatives and
meat from animals that consumed corn are reflected in
the measurement. 13C was shown to be correlated with
whole corn intake and animal protein intake (r=0.15,
0.28, respectively) [34]. A second isotope, 15N, may be
able to account and correct for animal protein intake
[35]. Overall, 13C measures have shown promise as they
can distinguish low from high sugar consumers [22], and
have demonstrated significant correlations between SSB,
added sugars and cane sugar/HFCS. Further research is
needed to refine this added sugar biomarker and estab-
lish the intake period reflected by the measurement.
Sugar. Urinary sucrose and fructose have been
investigated as possible biomarkers of sugar intake.
Urinary sucrose, fructose and combined sucrose/fruc-
tose are associated with sugar intake (R2=0.86, 0.80,
0.89, respectively), and are reproducible (ICC=0.44,0.81, 0.67, respectively) (examined using thirty 24-hour
urine samples) [36]. Urinary sucrose and fructose con-
centrations did not significantly differ between normal
and obese individuals when using a sugar controlled
diet [37]. Kuhnle et al. [38] examined two analytical
methods of determining urinary sucrose, gas chroma-
tography mass spectrometry (GC-MS) and liquid chro-
matography mass spectrometry (LC-MS). GC-MS is
able to identify more compounds than LC-MS, but the
sample preparation for GC-MS is more labor-intensive
and the analysis takes longer to conduct as it is examin-
ing more compounds than LC-MS.
Urinary sucrose and fructose are able to detect changes
in sugar intake [36], classify an individual as a high or
low sugar consumer and are suitable for those of normal
and obese weight status [37]. As well, both the LC-MS
and GC-MS analytic methods predicted urinary sucrose
as a suitable biomarker of sugar intake [38]. However, a
major limitation of urinary sucrose and fructose is the
capability to only reflect short term intake. Further re-
search is needed to develop a biomarker of total sugar in-
take that is reflective over a longer period of time (i.e.,
habitual intake).
Whole grain wheat and Rye
Several studies have examined plasma alkylresorcinol
(AR) concentrations as a possible whole grain wheat/rye
biomarker. Total plasma AR increases with whole grain
intake and decreases with refined bread intake after one
week [39]. Fasting plasma AR demonstrated high to
moderate reproducibility, ICC>0.88 (8 time points) [40],
r=0.38 (2 time points) [41] and was correlated with
whole grain intake (r=0.58) [31], (R2=0.94) [39], and rye/
wheat intake (r=0.53) [41]. Non-fasting plasma AR con-
centrations were found to be significantly higher com-
pared to fasting concentrations, however a moderate
significant correlation of r=0.50 (p<0.05) between fasting
and non-fasting was determined [41]. Red blood cell
(RBC) AR increases and decreases with whole grain in-
gestion, and also correlates with plasma AR (R2=0.85)
[39]. However, AR may be retained in RBC membranes
during low AR intake [39]. Investigation of enterolactone
(ENL), the main end-product of whole grains, revealed
its poor function as a biomarker of whole grain intake,
as it is a non-specific biomarker that has many dietary
sources and varies greatly between genders [39]. AR
homolog C17:0/C21:0 ratios have the potential to differ-
entiate between types of whole grain intake, specifically
wheat and rye [31,39,40].
3,5-dihydroxybenzoic acid (DHBA) and 3-(3,5-dihy-
droxyphenyl)-propanoic acid (DHPPA) are two metabolites
of AR that are excreted through urine. Urinary DHBA and
DHPPA were both found to be significantly correlated with
total plasma AR (r=0.481, 0.450, respectively, no p values
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cantly correlated with DHBA and DHPPA, as well as
plasma AR [42]. Recovery was shown to decrease with high
AR doses; it could be that a 24-hour urine collection was
not enough time to recover the high dose. DHBA and
DHPPA were able to demonstrate a higher dose-response
effect than plasma AR at low intake levels [43].
Total plasma AR appears to be a possible short term
(half-life approximately four hours) biomarker of whole
grain intake when assessing dose-response [43]; con-
versely, reproducibility has been shown over a 2-3
month period, which indicates a medium term marker.
However, AR may accumulate over periods of high in-
take, thus over-estimating intake at high levels and
under-estimating at low levels [31,40,43]. RBC AR may
be a longer term indicator of whole grain intake than
plasma AR, as they retain AR. Urinary DHBA and
DHPPA may provide a comparable indicator of whole
grain intake as plasma AR, while being minimally inva-
sive [42]. Further research is needed to assess effects of
various other whole grains on the AR homolog C17:0/
C21:0 ratio, in addition to determining the time period
being reflected.
Fats
The current lack of a valid total fat dietary biomarker
has hindered research targeting direct relationships of
fat intake with cardiovascular disease, as dietary fat in-
take assessment has largely relied on subjective data
[4,44]. The composition of fatty acid intake can be
reflected in the measurements of blood cholesterol (e.g.,
LDL, HDL); however, the role of genetics must be
acknowledged as having an effect on blood levels as well
[14]. Nonetheless, actual intake of specific fatty acids
(mono-unsaturated [MUFA], poly-unsaturated [PUFA]
and saturated fatty acids [SFA]), which may be indicators
of disease risk, is difficult to capture [4,45]. Additionally,
intake of omega-3 fatty acids, eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA), have been
linked with reduced cardiovascular disease risk; however,
current methods of determining actual intake have
proven to be costly and time-consuming [46]. Thus, re-
search is needed to develop biomarkers that are cost-
effective and able to detect dietary fat/fatty acid intake.
Total fat
Dietary biomarkers that represent total fat intake have
demonstrated conflicting results. Fatty acid RBC concen-
trations of MUFA, PUFA and SFA do not appear to be
adequate biomarkers of total fat intake, especially SFA.
Also, EPA, DHA and oleic acid may provide short term
biomarkers of relative intake but not total fat intake
[47]. King et al. investigated the possibility of using a
combination of fatty acids to create a biomarker of totalfat intake. Using three different biological samples (i.e.,
RBC, plasma phospholipids (PL) and cholesterol esters
(CE)), to measure fatty acid status, three prediction
models were produced that had high sensitivity and spe-
cificity (all >90%) in discerning between low fat/high fat
intakes [44]. Trans-fats were a common indicator of
total fat intake for all models, but it may be less useful
as a biomarker as trans-fats are being removed from
many foods. RBC markers may be a useful long term
marker, as the RBC turnover is approximately 120 days;
RBC also showed smaller changes in fatty acid compos-
ition compared to PL and CE measures [44]. Thus, util-
izing a combination of various fatty acids may prove to
be a biomarker of total fat intake.
Fatty acids
Several studies examining biomarkers of relative fatty
acid intakes have produced favorable outcomes. PUFA
measured in adipose tissue showed strong correlations
with dietary intake (r=0.15-0.58), specifically linoleic
and alpha-linolenic acids [45]. Others have suggested
that n-6 and n-3 PUFA in PL is a long-term biomarkers
of relative intake (r=0.16, 0.29, respectively) [48]. A study
comparing pre- to post-menopausal women reported a
significant correlation between RBC and PUFA in post-
menopausal women (r=0.39), but not pre-menopausal
(r=0.17) [49], and correlations between RBC MUFA and
relative intake (r=0.40-0.48) [49]. Also, plasma MUFA
cis18:1n-9 was reported to be a long-term biomarker for
total MUFA (r=0.22) [48]. RBC Oleic acid was found to
be a valid biomarker of intake (r=0.45-0.47) [49], but
RBC SFA does not appear to be a valid intake biomarker
[49]. However, serum SFA 15:0 correlated with total SFA
dietary intake (r=0.19) [48]. Adipose trans-fatty acids
were also shown to correlate significantly with dietary in-
take (r=0.43) [45].
According to existing literature, adipose and plasma
PUFA levels appear to be the best indicators of relative
intake; RBC PUFA levels warrant additional research as
correlations differed between population groups. RBC
and plasma MUFA appear to be valid measures of
MUFA intake, while RBC SFA does not appear to be a
valid indicator of intake. Serum SFA measures show po-
tential as biomarkers, but trans-fatty acid biomarkers
may not be as useful due to reductions in the food sup-
ply in recent years.
Essential fatty acids
Alpha-linolenic and linoleic acid are two essential fatty
acids (EFA). Significant tissue-dietary correlations of
alpha-linolenic and linoleic acid, respectively, in adipose
tissue (r=0.51, 0.52), fasting blood (r=0.38, 0.43) and
fasting plasma levels (r=0.39, 0.41) have been reported
[50]. Others [49] have noted a significant correlation
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(r=0.23 pre-menopausal, 0.39 post-menopausal), but not
for RBC alpha-linolenic acid. Fasting blood is compar-
able in results to plasma and adipose tissue, less expen-
sive and less invasive than adipose tissue sampling.
Thus, whole blood measures appear to be the ideal indi-
cator of long-term linoleic acid intake, and possibly
alpha-linolenic acid [50].
Eicosapentaenoic acid and docosahexaenoic acid
EPA and DHA are omega-3 fatty acids primarily
obtained from fish consumption [46]. Levels of plasma
EPA and DHA, when compared to their relative dietary
intake, produce significant correlations (EPA, r=0.57
males, 0.60 females; DHA, r=0.57 males, 0.30 females)
[51]. The stable isotope 15N is associated with fish in-
take; thus, levels of EPA and DHA 15N were assessed in
blood and hair samples. Dietary EPA and DHA were cor-
related with blood 15N levels (r=0.47, 0.46, respectively)
[46]. Hair 15N was correlated with dietary EPA and DHA
(r=0.83, 0.84, respectively) [52]. However, because 15N
can be influenced by intake of other sources of animal
protein (beef, etc.) feeding studies should be completed
to further evaluate this biomarker’s specificity. As the
availability of EPA and DHA fortified food items (bread,
cereal, etc.) and supplements has increased over the past
several years, and due to the amount of EPA and DHA
varying within types of fish, this biomarker must be
acknowledged to be a biomarker of EPA and DHA intake
and not fish consumption.
Plasma EPA and DHA may be useful dietary biomar-
kers of their respective intake; further research is required
to determine the time-period of intake reflected. Blood and
hair 15N both provide accurate biomarkers of EPA and
DHA intake. The turnover of EPA and DHA differ, thus
RBC 15N levels may be providing indicators for two dif-
ferent time periods [46]. Hair 15N is able to reflect the
previous two months of intake [52]. Plasma EPA and
DHA, RBC and hair 15N all show potential as biomarkers
of EPA and DHA intake; yet, further research is needed
to determine dose-response as well as intake periods
being measured.
An additional biomarker of omega-3 fatty acid intake,
known as the Omega-3 Index, is the sum of EPA and
DHA in RBC membranes, expressed as a percent of total
fatty acids [53]. The validity and dose-response of the
index was assessed by having 57 subjects randomized
into 4 varying dose supplementation groups and was
then compared to plasma phospholipid and whole blood
EPA and DHA. Correlations between the Omega-3
Index and plasma phospholipid and whole blood EPA
and DHA were both found to be significantly correlated,
r=0.91, p<0.001, p<0.0001, respectively. Additionally, sig-
nificant dose-responses were demonstrated between thevarying intake levels. Significant changes from baseline
levels were also found in all intake groups, with the ex-
ception of the 2 highest intake levels, which may indi-
cate a ceiling effect [53]. Additional testing is required to
assess the reliability of the Omega-3 Index, as well as
the time period being assessed.
Olive oil
Lower incidences of cardiovascular disease have been
associated with diets where olive oil is a major contribu-
tor to fat intake [54]. Tyrosol and hydroxytyrosol are
two phenolic compounds derived from olive oil intake.
Tyrosol shows a strong dose-response effect in 24-hour
urine samples, as well as similar recovery for a single
dose and a week of sustained doses (16.9%, 19.4%, re-
spectively). Hydroxytyrosol had a recovery of 78.5% after
a single dose and 121.5% recovery after a week of sus-
tained intake. This reveals that hydroxytyrosol probably
accumulates as the recovery was higher than the intake
of olive oil; additionally, hydroxytyrosol can also be
derived from other sources, including endogenous
sources [54]. Although further research is needed, tyro-
sol shows promise as a biomarker of olive oil intake.
A dietary biomarker of protein intake may be useful
for determining nutritional status (over/under nour-
ished). In addition, animal protein intake has been linked
to increased risk of cancer, obesity, diabetes and the
metabolic syndrome [55]. However, research determin-
ing the long-term effects of dietary protein intake is
lacking due to the absence of a valid biomarker.
Total protein
Urinary nitrogen is a valid method of assessing total pro-
tein intake, though several limitations exist. A compari-
son of a 28-day feeding study with multiple 24-hour
urine nitrogen outputs produced a correlation of 0.99.
When the time period is reduced to a single observation,
the correlation is reduced to 0.50, but improves to a cor-
relation of 0.95 with 18 days (p values not reported)
[56]. To obtain the most accurate measurements, indivi-
duals should maintain a constant daily intake and be in
nitrogen balance. Urinary nitrogen may underestimate
high protein intake levels and overestimate at low intake
levels, yet it is considered an adequate biomarker of pro-
tein intake. It is suggested that multiple 24-hour urine
samples are needed to fully establish protein status [56].
Animal protein
As discussed previously, isotopes 13C and 15N are po-
tential dietary biomarkers for added sugars and fatty
acids [22,32-35,46,52]. These isotopes have also been
evaluated for their potential to measure animal protein
intake via 15N and 13C hair, yet baseline measurements
showed low correlations with dietary intake (R2=0.17,
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decreased protein intake has been reported, but not a sig-
nificant increase with increased protein intake after four
weeks. Thus, hair 15N and 13C do not appear to be valid
short term dietary biomarkers of protein intake, but fur-
ther research is needed to determine if they could be
valid longer-term biomarkers [55]. Several potential bio-
markers of red meat intake have been identified, creatin-
ine, taurine, 1-methylhistidine, and 3-methylhistidine.
These components are specific to meat intake and are
excreted in the urine [57]. Two randomized crossover
studies examined the mean levels of each component
with four dietary conditions, three varying levels of red
meat intake and one vegetarian diet. All components
demonstrated a significant dose-response to the in-
crease of red meat intake (Ptrend<0.0001). Furthermore,
1-methylhistidine and 3- methylhistidine demon-
strated significant differences in the means across the
four dietary conditions (all p<0.03). Taurine and cre-
atinine did not appear to be as sensitive to intake and
were not able to distinguish between the low red meat
and the vegetarian diets. (p=0.95, 0.88, respectively)
[57]. 3- methylhistidine and creatinine can be formed
during muscle catabolism, thus, as markers of red
meat intake they could potentially be falsely elevated.
Furthermore, 3- methylhistidine was shown to have
greater variance among participants on the same diet;
the same was not demonstrated with 1- methylhisti-
dine, which may be the most promising biomarker of
the four components. This study had participants
consume the respective diet for 15 days, with three
24-hour urine collections occurring on the final three
days. Because no washout period was used, it is diffi-
cult to determine the time period measured. The half-
lives of 1- and 3- methylhistidine are reported to be
approximately 12 hours; thus, they are both consid-
ered short term biomarkers of red meat intake [57].
Further research reporting the reproducibility and the
intake period being measured is needed.
Various foods/dietary components
Table 2 presents a summary of the various food/dietary
component biomarker studies that could not be categor-
ized within a macronutrient category, as follows: caf-
feine, citrus, cocoa, garlic and wine.
Caffeine
Caffeine intake is difficult to assess via questionnaires
and dietary recalls, as caffeine concentrations can vary
greatly among different foods/beverages and may not be
present in many nutritional software databases. However,
due to the potentially harmful side effects of high caffeine
intake, it may be important to develop acceptable intake
levels and a biomarker that reflects consumption [58].Caffeine (137X) is broken down into four known meta-
bolites in the urine, 17X, 17U, 1X, AFMU. Caffeine, in its
un-metabolized form, and AFMU are greatly influenced
by inter-individual differences (e.g., genetic variability)
and are not acceptable indicators of caffeine intake. Al-
though 17X is minimally influenced by genetic variability
and shows significant correlation with caffeine intake
(R2=0.58), it requires more research before it is consid-
ered a valid biomarker of intake. 17U and 1X are both
minimally influenced by inter-individual differences,
show high correlations with intake (R2=0.87, 0.78, re-
spectively) and may be acceptable biomarkers of caffeine
consumption [58].
Citrus
Total fruit and vegetable intake is difficult to objectively
quantify due to most biomarkers measuring the effect of
fruit and vegetables on health outcomes (e.g., reduction
of oxidative biomarkers [59]) or intake of non-specific
nutrients, such as Vitamin C (which is found/added in
many dietary items) [4]. However, proline betaine was
identified through nutrimetabolomic metabolic profiling
as a possible marker of citrus consumption, which may
be able to identify true intake of citrus fruits. Proline
betaine was shown to be sensitive (86.3%), specific
(90.6%) and significantly correlated with citrus consump-
tion (R2=0.40). A limitation of proline betaine is its rapid
urinary excretion, (i.e., 24 hours after intake) [21]. Lloyd
et al. [60] demonstrated the ability of urinary proline
betaine levels to differ among low, medium and high cit-
rus consumers after an overnight fast. Levels of proline
betaine were assessed throughout the study; however,
oranges were the only citrus source used. Additionally,
two metabolites, specific to orange intake, were identi-
fied: hesperidin and nariruin. However, they were found
to be insufficient indicators of citrus intake. The study
concluded that additional sensitivity and specificity of
proline betaine, with additional intake of varying citrus
foods, is necessary before it can be considered a useful
dietary biomarker [60].
Cocoa
Cocoa is a major source of phytochemicals (phenolic com-
pounds), which have been shown to improve cardiovascu-
lar health and antioxidant status [61]. A study utilizing
metabolomic metabolic profiling identified twenty-seven
cocoa urinary metabolites that occurred over the 24-hour
period following intake [61]. Additional research on the
various identified cocoa metabolites should be conducted
in order to develop a valid biomarker of cocoa intake.
Garlic
It has been hypothesized that garlic may provide chemo-
preventive effects; thus, the development of a biomarker
Table 2 Summary of recent biomarker studies on various food/dietary components
Food/Dietary
component











Caffeine Crews et al.
(2001)
Caffeine (137X) (8 adults) Urine (24 hr) HPLC Short term
Caffeine Metabolite: 17X Urine (24 hr) HPLC Short term R2=0.58*
Caffeine Metabolite : 17U Urine (24 hr) HPLC Short term R2=0.87*
Caffeine Metabolite: 1X Urine (24 hr) HPLC Short term R2=0.78*
Caffeine Metabolite: AFMU Urine (24 hr) HPLC Short term
Citrus Heinzmann et al.
(2010)





Proline betaine (23 adults) Urine (fasting) FT-ICR-MS Short term?
Hesperidin Urine (fasting) FT-ICR-MS
Nariruin Urine (fasting) FT-ICR-MS




Urine HPLC-q-TOF Short term
Garlic Verhagen et al.
(2001)
S-allyl-mercapturic acid
(ALMA) (101 male adults)
Urine (24 hr) GC-MS Short term




Urine (fasting) LC-MS/MS Short term +












Blood & Urine LC-ESI-MS/MS Short term
aHPLC, High-performance liquid chromatography; 1H NMR, 1H Nuclear magnetic resonance spectroscopy; FT-ICR-MS, Linear trap quadrupole-Fourier-transform ion cyclotron
resonance mass spectroscopy ultra; HPLC-q-TOF, High-performance liquid chromatography with time of flight mass spectrometry; GC-MS, Gas chromatography-mass
spectrometry; LC-MS/MS, Liquid chromatography-tandem mass spectrometry; LC-ESI-MS/MS Liquid chromatography-electrospray ionization/multi-stage mass spectrometry.
bShort term: hours/days; Medium term: weeks/months; Long term: months/years.
cResults of comparsion of biomarkers to an appropriate dietary assessment method.
dRepresentative values from the literature.
eBiomarker is able to detect changes in intake over time or distinguish high from low consumers; + = sensitivity has been demonstrated.
*Significance not reported.
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prevention, as well as prevention of other chronic dis-
ease [62]. S-allyl-mercapturic acid (ALMA) has been
identified as a urinary metabolite of dietary garlic intake.
In a research investigation, the presence of ALMA was
detected in the majority of garlic consumers (fifteen out
of sixteen), while only two control subjects out of four-
teen had detectable levels of ALMA. Therefore, ALMA
appears to differentiate garlic consumers from non-con-
sumers. However, ALMA is a short term biomarker of
garlic intake as the half-life is approximately six hours,
and ALMA may increase with other sources; it is not
specific to garlic intake [62].
Wine
Resveratrol, a phenolic compound found in wine, has
been shown to be negatively correlated with cardiovas-
cular disease [63]. A biomarker for wine intake may
prove to be useful, as individuals may not always accur-
ately report alcoholic beverage consumption due to so-
cial undesirability (2). Metabolites of resveratrol have
been discovered in urine and plasma, and total resvera-
trol metabolites (TRM) were analyzed to determineexposure and responsiveness of wine intake. Plasma
TRM have an extremely short half-life of approximately
two hours, and only reflect very recent intake. Urinary
TRM, however, may differentiate between wine drinkers
and non-drinkers with high sensitivity and specificity
(73%, 93%, respectively). TRM also show a strong dose-
response effect. A limitation of TRM is that it only
reflects intake of regular consumers and may prove less
useful in intermittent consumers of wine [63].
A later study demonstrated the ability of urinary
resveratrol metabolites to be significantly correlated
with wine intake (r=0.895, p<0.001) and also estab-
lished sensitivity (93.3%) and specificity (92.1%) be-
tween consumers and non-consumers [64]. Further
research is needed to be able to objectively classify
consumers into groups based on their wine consump-
tion levels [65]. Certain limitations exist, such as
resveratrol is not specific to wine intake and can be
found in grapes, peanuts, and berries; furthermore,
the amount of resveratrol can vary between types of
wine [64].
Rotches-Ribalta et al. [66] used mass spectrometry to
identify resveratrol metabolites after ingestion of red
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tified, including trans- and cis-resveratrol and trans- and
cis-piceid. Significant differences were found between red
wine consumption and pharmaceutical ingestion of grape
extract, which suggests further research is needed to as-
sess resveratrol metabolism. Specifically, it has been
shown that resveratrol has low bioavailability and a com-
plex diet (especially fiber intake) may affect the concen-
trations of the metabolites. Colonic microflora also play a
role in producing resveratrol’s metabolites, which is in
need of further investigation as intra-individual micro-
flora variability is high [66,67].
Conclusions
Biomarkers of dietary exposure should be valid, reprodu-
cible, able to detect changes in intake over time and be
suitable for the general population. Yet, many of the
dietary biomarkers reviewed appeared inadequate at
meeting all of the aforementioned criteria (see Tables 1,
and 2). The majority of reviewed studies only examined
the validity of a biomarker (twenty-two studies); four
studies evaluated reproducibility and eight studies evalu-
ated the biomarker’s ability to be sensitive to changes in
respective dietary intake. The best biomarkers available
show validity, reproducibility and sensitivity; this review
identified two biomarkers that met all three criteria:
combined urinary sucrose and fructose for a sugar bio-
marker (33) and total plasma alkylresorcinol for a whole
grain biomarker (28, 37). Additionally, fingerstick 13C
measurements demonstrated validity and reproducibility
for cane sugar/HFCS intake (19), and urinary proline
betaine demonstrated validity and sensitivity for citrus
consumption (18).
There are multiple factors that warrant investigation
before many of these biomarkers can be more widely
utilized in nutrition and health research. Genetics, age,
type of specimen, time of year, and confounding diet-
ary sources play a pivotal role in the feasibility and
validity of dietary biomarkers. This literature review
indicated more research was needed for many macronu-
trient biomarkers, as well as novel indicators of specific
foods/dietary components intake which could not be
categorized within macronutrients. Furthermore, few
biomarkers demonstrated cost-effectiveness and non-
invasiveness (e.g., hair or fingerstick vs. venipuncture or
adipose tissue). Emphasis should be placed on developing
biomarkers using samples that are minimally invasive
with a low subject burden (e.g., fasting). The practicality
of the measure is also an important consideration, in-
cluding the accessibility, collection, processing, storage
and analysis of the specimen [2]. Common limitations
to this body of literature include small sample sizes
(less than 20 participants) [21,33,36,38-40,43,47,51,54-
58,61,63,66] and lack of variability in participant’s gender[40,42,44,47-49,51,55,57,62,66], race [45,46,50-52], and age
[33,34,44,45,50,55]. It should be taken into consideration
that is a limited nonsystematic review in the emerging
area of dietary biomarkers. Furthermore, no quality as-
sessment of the included literature was conducted; there-
fore, discretion should be used when interpreting findings.Future directions
Biomarkers are needed to provide objective measures of
nutrient status, which is a commonly cited limitation of
subjective dietary assessment methods. However, some
dietary intake methods use biomarkers to validate the
data being collected. As noted by The Institute of Medi-
cine, the need to expand upon dietary assessment meth-
ods is critical [10]. Biomarkers that will allow for the
assessment of specific consumption of items which
could be deemed socially undesirable, such as sugar-
sweetened beverages or high fat/saturated fat foods,
without confounds of human subjective nature need to
be developed [13]. Future research pertaining to biomar-
kers should emphasize the development of biomarkers
for evaluating adherence to national recommendations
for specific food groups such as the U.S. 2010 Dietary
Guidelines (e.g., whole grains, fruits and vegetables, low
fat/fat free dairy products, added sugar) [29]. Future re-
search should be directed at refining existing biomarkers
by accounting for confounding factors, establishing new
indicators of specific food intake and developing techni-
ques that are cost-effective, noninvasive, rapid and ac-
curate measures of nutritional status. The emerging field
of metabolomics in human nutrition, as well as the de-
velopment of valid FFQ and the continued expansion of
food metabolome databases will permit the identification
of specific dietary components in food, produce more
valid biomarkers of exposure to certain foods and pos-
sibly advance nutritional science research which aims to
evaluate diet and disease relationships.
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